How Regenerative Medicine Can Better Manage Parkinson’s Disease

Introduction: Understanding Parkinson’s Disease

For decades, Parkinson’s treatment has focused on managing symptoms- but with the emergence of regenerative medicine, could damaged neurons be restored?

Parkinson’s Disease (PD) is a progressive neurological condition that worsens with time. The condition appears when brain cells do not produce adequate amounts of dopamine (a neurotransmitter hormone). Parkinson’s Foundation reflects more than 10 million individuals living with PD globally. The global incidence reflects that the cases increase with age. Men are 1.5 times more vulnerable to developing PD in comparison with women [1]. 

The current available treatment insights for Parkinson’s Disease (PD) are mainly non-curative. With the emergence of regenerative technology, reversing neuronal damage now appears to be a promising possibility. 

Ask The Expert

What Is Parkinson’s Disease?

Parkinson’s disease is caused by progressive degeneration of the substantia nigra that significantly reduces dopamine production. This leads to the formation of a protein clump known as ‘Lewy body’ that builds up neuroinflammation. Dysregulation of protein results in cognitive decline, mood change, and autonomic systemic issues. PDs are subcategorized into two types:

• Idiopathic PD: The exact causes are unknown. Research reflects inappropriate folding in the alpha-synuclein protein in the brain (Lewy bodies). The buildup of the protein leads to brain damage. 
• Familial (genetic) PD: caused by genetic predisposition. This type might appear at an early life stage.

Parkinson’s Disease Causes and Risk Factors

Parkinson’s disease causes and associated risk factors includes:

• Degeneration of dopaminergic neurons. This leads to a compromised ability of the body to send signals to your muscles. This leads to tremors, slow movements, and stiffness. The progression of the condition leads to compromised thinking, mood, or memory issues. 
• Genetic mutations (LRRK2, PARK genes)
• Exposure to environmental conditions, such as long-term exposure to metals or pesticides
• Age factor, gender (males are more prone) and oxidative stress

Common Parkinson’s Disease Symptoms

PD symptoms begin with mild symptoms that progress to more serious conditions. The symptoms include:

• Slow movement
• Tremors in hand and legs
• Muscle stiffness
• Stooped stances, change in posture and walking
• Cognitive impairment, depression, agitation, and autonomic dysfunction
• Insomnia and restlessness
• Sensory dysfunction, such as loss of smell

Parkinson’s Disease Treatment

Neurologists recommend Parkinson’s Disease Treatment to manage the symptoms and improve quality of life. The major treatment approach involves:

• Dopamine Replacement Therapy: Levodopa converts dopamine in the brain, and carbidopa boosts the action of levodopa and reduces nausea. A dopamine agonist acts as dopamine in the brain.
• Deep Brain Stimulation (DBS): Surgical intervention where a device is introduced for managing movement symptoms
• Physiotherapy: For muscle strengthening and improving blood circulation in limbs 
• Lifestyle and Supportive Care: Introduction of dietary intervention to manage the nutritional needs of individuals

*The above conventional treatment targets managing the symptoms and improving the quality of life of patients. However, there is a greater need for a curative approach that can potentially reverse the neuronal damage.

How Regenerative Medicine Is Emerging in Parkinson’s Treatment

Regenerative medicine in forms of stem cell therapy is taking a bigger leap in Parkinson’s disease treatment. This involves stem cell transplantation into the brain that can regenerate into new neurons and replace the damaged cells. The cells stimulate the regeneration of dopamine-producing neurons. Stem cell involves multiple mechanisms that potentiate cellular revival. This includes:

• Regeneration of Dopamine-Producing Neurons: Mesenchymal stem cells (MSCs) have the potential to differentiate into distinct cell types. The cells are either differentiated into laboratory environments, followed by implantation. The other way is to direct implantation of the cells in the striatum. 
• Neuroprotection and Cellular Signalling: MSCs release various neurotrophic factors such as BDNF, GDNF, etc. These molecules protect the naive differentiated neuronal cells and existing cells. 
• Neuroinflammation: MSCs release various anti-inflammatory factors such as TNF-α, IFN-γ, etc. These molecules introduce anti-inflammatory signalling, reducing the neural inflammation. 
• Endogenous Repair Mechanism: MSCs modulate the brain’s own repair mechanism, creating a supportive microenvironment. The activation of the repair mechanism supports the existing neuron cells [2].

What Does Preclinical & Clinical Evidence State?

Preclinical and clinical studies reflected the safety of using stem cell therapy for Parkinson’s disease. The evidence showed:

• Reduction of Motor Symptoms: The severity of Parkinson’s symptoms, like tremors, bradykinesia, and rigidity, was significantly reduced among patients
• Improvement in Balance and Coordination: Enhancement of postural stability, improved coordination reported. Significant reduction in risk of falls
• Reduction in Medication Dependency: In several clinical trials, patients reported reduced dependency on medication along with improvement in symptoms. 
• Enhanced Quality of Life: Better quality of motor function, muscle memory, and coordination improved the quality of life of patients [3, 4]

What do Outcomes Say About Stem Cell Therapy?

Currently, stem cell therapy for Parkinson’s disease is at an early stage. The results vary among individuals depending on their health assessment, symptoms severity, quality of stem cells, cell source, and patient’s response. Some individuals encountered substantial improvement in symptoms, while others showed moderate to incremental changes. 

The controlled key factor is the implantation of superior quality stem cells isolated from sterile sources. 

*Advancells, India, is one of the leading stem cell research laboratories that isolates and maintains superior quality stem cells ideal for various neurodegenerative diseases, including PD.

What Makes Stem Cell Therapy Superior?

Stem Cell Therapy for Parkinson’s Disease offers several advantages over other conventional treatments. This includes:

• Stem cell therapy targets the root cause of the disease rather than focusing on symptom management. 
• Patient’s reduction in medication reliance, reduction of long-term medication-associated side-effects
• Long-term positive outcomes in many patients who showed sustained improvement
• Tailored treatment development based on the patient’s individual needs
• Minimally invasive, safe, and well-tolerate among patients

Future Prospects of Regenerative Medicine for Parkinson’s Disease

• Development of personalized stem cell-based therapy based on the patient’s needs
• Standardization of cell source, isolation methodology and administration route for ensuring the best outcomes
• Combination with gene editing and CRISPR-Cas 9 approach
• Combination of stem cell therapy with neuroprotective drugs
• Introduction of large-scale clinical trials for ensuring the long-term safety of stem cell therapy

Conclusion: Toward Disease-Modifying Therapies for Parkinson’s

Parkinson’s disease is a critical chronic condition affecting a large number of individuals. The disease presents significant challenges impacting the quality of life of patients. The conventional treatment does not comply with the curative approach. With the emergence of stem cell therapy for PD, the treatment landscape looks promising. The changes occur at the cellular level, hence targeting the disease root cause. In the future, the standardization of cell source, isolation technique, dosage, and administration technique is crucial. Conducting large-scale clinical trials is necessary for determining long-term treatments. 

Parkinsons Disease Patient Success Stories

References

1. Parkinson’s Foundation. Statistics [Internet]. New York (NY): Parkinson’s Foundation. Available from: https://www.parkinson.org/understanding-parkinsons/statistics
2. Stoddard-Bennett T, Pera RR. Stem cell therapy for Parkinson’s disease: safety and modeling. Neural Regeneration Research. 2020 Jan 1;15(1):36-40.
3. Jeon J, Cha Y, Hong YJ, Lee IH, Jang H, Ko S, Naumenko S, Kim M, Ryu HL, Shrestha Z, Lee N. Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease. Cell Stem Cell. 2025 Mar 6;32(3):343-60.
4. Jang SE, Qiu L, Chan LL, Tan EK, Zeng L. Current status of stem cell-derived therapies for Parkinson’s disease: from cell assessment and imaging modalities to clinical trials. Frontiers in neuroscience. 2020 Oct 16;14:558532.

FAQ’s

Q- What is Parkinson’s Disease?

Parkinson’s is a neurodegenerative condition that critically impacts coordination and movements in affected individuals. The disease develops due to progressive degeneration of dopamine-producing neurons.

Q- What are Common Symptoms of Parkinson’s?

The common symptoms include muscle rigidity, bradykinesia, bad posture, problems with coordination, tremors, etc. Some other symptoms include insomnia, fatigue, mood swings, cognitive impairment, etc. 

Q- What are the Treatments Available for Parkinson’s?

Treatment includes medications that increase or mimic dopamine activities. Other treatments include DBS, physiotherapy, nutritional interventions, and lifestyle modifications. 

Q- Is Stem Cell Therapy for Parkinson’s Safe?

Preclinical and clinical studies have reflected the safety and efficacy of stem cell therapy for PD. Currently, the therapy is still at an early stage. In the future, there is an immense need to conduct large-scale clinical trials to determine long-term safety and outcomes.